NCT00194090

Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk

A Double-blind, Placebo-controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 mg qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: University Hospitals Cleveland Medical Center · Academic / Other
• Sex: All
• Age: 45 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis

Detailed description

This is a randomizd, placbo-controlled, crossover trial comparing a single dose of celecoxib to placebo measuring the time to onset of acute pain in a paced 20-minute walk. 40 subjects will be enrolled

Conditions

• Knee Osteoarthritis

Interventions

Type	Name	Description
DRUG	celecoxib

Timeline

• Start date: 2004-06-01
• Primary completion: 2005-09-01
• Completion: 2005-09-01
• First posted: 2005-09-19
• Last updated: 2022-08-26

Locations

1 site across 1 country: United States